QUIA.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:29):

Stats
Today's Volume	864 461
Average Volume	1.45M
Market Cap	5.33M
EPS	SEK-1.220 ( 2022-12-31 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-2.46
ATR14	SEK0.00200 (2.71%)

Volume Correlation

Long: -0.12 (neutral)

Short: -0.35 (neutral)

Signal:(43.515) Neutral

QuiaPEG Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

QuiaPEG Pharmaceuticals Correlation - Currency/Commodity

0.00
( neutral )

-0.15
( neutral )

0.00
( neutral )

-0.41
( neutral )

QuiaPEG Pharmaceuticals Financials

Annual	2023
Revenue:	SEK4.37M
Gross Profit:	SEK2.29M (52.42 %)
EPS:	SEK-0.0335

Q4	2023
Revenue:	SEK1.32M
Gross Profit:	SEK714 000 (54.23 %)
EPS:	SEK-0.00340

Q3	2023
Revenue:	SEK1.32M
Gross Profit:	SEK714 000 (54.23 %)
EPS:	SEK-0.00340

Q2	2023
Revenue:	SEK870 500
Gross Profit:	SEK371 500 (42.68 %)
EPS:	SEK-1.000

Financial Reports:

No articles found.

QuiaPEG Pharmaceuticals

QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.